Author:
Reyes Charlene,Groshel Carla,Given Robert
Publisher
Springer International Publishing
Reference40 articles.
1. Nelson JB. Hormone therapy for prostate cancer. In: Campbell-Walsh urology, vol. 3. 10th ed. Amsterdam: Elsevier Inc; 2012. p. 2935.
2. Hanks GE, Pajak TF, Porter A, Grignon D, Brereton H, Venkatesan V, Horwitz EM, Lawton C, Rosenthal SA, Sandler HM, Shipley WU, Radiation Therapy Oncology Group. Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02. J Clin Oncol. 2003;21(21):3972–8.
3. D’Amico AV, Manola J, Loffredo M, Renshaw AA, DellaCroce A, Kantoff PW. 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. JAMA. 2004;292(7):821–7.
4. Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Yao SL. Survival following primary androgen deprivation therapy among men with localized prostate cancer. JAMA. 2008;300(2):173–81. https://doi.org/10.1001/jama.300.2.173 .
5. Denmeade SR, Isaacs JT. Overview of regulation of systemic androgen levels. In: Holland-Frei cancer medicine. 6th ed. Hamilton: BC Decker Inc; 2003.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献